Cancer-related microangiopathic hemolytic anemia: Clinical and laboratory features in 168 reported cases

Medicine (United States)

Volumn 91, Issue 4, 2012, Pages 195-205

  Lechner, Klaus ^a   Obermeier, Hanna Lena ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ADULT; AGED; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW BIOPSY; BREAST CANCER; CANCER OF UNKNOWN PRIMARY SITE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RELATED MICROANGIOPATHIC HEMOLYTIC ANEMIA; CANCER SURVIVAL; CANCER THERAPY; COOMBS POSITIVE HEMOLYTIC ANEMIA; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOCRINE TUMOR; FEMALE; HEMOLYTIC UREMIC SYNDROME; HODGKIN DISEASE; HUMAN; HYPOFIBRINOGENEMIA; LARGE CELL LYMPHOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MYELOMA; PARANEOPLASTIC SYNDROME; PLASMAPHERESIS; PRIORITY JOURNAL; PROSTATE CANCER; REMISSION; REVIEW; SKIN NECROSIS; SOLID TUMOR; STOMACH CANCER; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AUSTRIA; CAUSE OF DEATH; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASMS; PARANEOPLASTIC SYNDROMES; PROGNOSIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84863719861     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e3182603598     Document Type: Review

References (160)

1. Abdel Samie A, Sandritter B, Theilmann L. Severe microangiopathic hemolytic anemia as first manifestation of a CUP syndrome. Rapid hematologic remission under polychemotherapy. Med Klin (Munich). 2004;99:148-153. (Pubitemid 38387678)
2. Ajani JA, Rodriguez W, Bodoky G, Moiseyenko V, Lichinitser M, Gorbunova V, Vynnychenko I, Garin A, Lang I, Falcon S. Multicenter phase III comparison of cisplatin/S-1 with cisplatin/infusional fluorouracil in advanced gastric or gastroesophageal adenocarcinoma study: the FLAGS trial. J Clin Oncol. 2010;28:1547-1553.
3. Akimoto T, Muto S, Ito C, Takahashi H, Takeda S, Ando Y, Kusano E. Clinical features of malignant hypertension with thrombotic microangiopathy. Clin Exp Hypertens. 2011;33:77-83.
4. Alexopoulou A, Dourakis SP, Nomikou E. Case of thrombotic thrombocytopenic purpura associated with disseminated gastric cancer. Am J Clin Oncol. 2002;25:632. (Pubitemid 35453675)
5. Ali N, Kamran N, Adil S, Pervez S. Metastatic signet ring gastric adenocarcinoma presenting with microangiopathic hemolytic anemia. Indian J Gastroenterol. 2007;26:185-186. (Pubitemid 350074984)
6. Al-Mondhiry H. Disseminated intravascular coagulation: experience in a major cancer center. Thromb Diath Haemorrh. 1975;34:181-193.
7. Alpay N, Uzun S, Bahat G, Yavuz S, Erten N, Tascioglu C. Thrombotic thrombocytopenic purpura associated with multiple myeloma. Blood Coagul Fibrinolysis. 2008;19:439-441.
8. Antman KH, Skarin AT, Mayer RJ, Hargreaves HK, Canellos GP. Microangiopathic hemolytic anemia and cancer: a review. Medicine (Baltimore). 1979;58:377-384. (Pubitemid 10234880)
9. Arkenau HT, MüssigO, Buhr T, Jend HH, Porschen R. Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: case reports and review of the literature. Z Gastroenterol. 2005;43:719-722. (Pubitemid 41233459)
10. Ataga KI, Graham ML. Microangiopathic hemolytic anemia associated with metastatic breast carcinoma. Am J Hematol. 1999;61:254-255. (Pubitemid 29355022)
11. Ay C, Pabinger I. Tests predictive of thrombosis in cancer. Thromb Res. 2010;125(Suppl 2):S12-15.
12. Basteck] J, Langr F, Chrobák L, Hlava A, Kvasnicka J. ETumor microembolization in the lungsVa cause of marked dyspnea, syncope, hemolytic syndrome and disorders of hemocoagulation. Vnitr Lek. 1992;38:505-512.
13. Bhagwati N, Seno R, Dutcher JP, Oleksowicz L. Fulminant metastatic melanoma complicated by a microangiopathic hemolytic anemia. Hematopathol Mol Hematol. 1998;11:101-108.
14. Bisetti A, Lalicata M, Jacot-des-Combes E. EOccult gastric adenocarcinoma with pulmonary carcinomatous lymphangitis and microangiopathic hemolytic anemia in a young adult. Schweiz Med Wochenschr. 1985;115:561-564. (Pubitemid 15092054)
15. Blot E, Decaudin D, Veyradier A, Bardier A, Zagame OL, Pouillart P. Cancer-related thrombotic microangiopathy secondary to Von Willebrand factor-cleaving protease deficiency. Thromb Res. 2002;106:127-130. (Pubitemid 35245236)
16. Brain MC, Azzopardi JG, Baker LR, Pineo GF, Roberts PD, Dacie JV. Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma. Br J Haematol. 1970;18:183-193.
17. Calvo Villas JM, Hernández JM, Cueto M, Cuenca C. EMicroangiopathic anemia and leukoerythroblastic reaction associated with a pulmonary adenocarcinoma. An Med Interna. 1996;13:356-357.
18. Caramello V, Dovio A, Caraci P, Berruti A, Angeli A. Thrombotic thrombocytopenic purpura in advanced prostate cancer: case report and published work review. Int J Urol. 2007;14:150-152. (Pubitemid 46121954)
19. Cardoso F, Bedard PL, Winer EP, Pagani O, Senkus-Konefka E, Fallowfield LJ, Kyriakides S, Costa A, Cufer T, Albain KS; ESO-MBC Task Force. International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy. J Natl Cancer Inst. 2009;101:1174-1181.
20. Carey RW, Harris N. Thrombotic microangiopathy in three patients with cured lymphoma. Cancer. 1989;63:1393-1397. (Pubitemid 19084563)
21. Carr DJ, Kramer BS, Dragonetti DE. Thrombotic thrombocytopenic Purpura associated with metastatic gastric adenocarcinoma: successful management with plasmapheresis. South Med J. 1986;79:476-479.
22. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 26-1984. Microangiopathic hemolytic anemia in a 53-year-old woman with metastatic breast cancer. N Engl J Med. 1984;310:1728-1736.
23. Cataland SR, Jin M, Smith E, Stanek M, Wu HM. Full evaluation of an acquired case of thrombotic thrombocytopenic purpura following the surgical resection of glioblastoma multiforme. J Thromb Haemost. 2006;4:2733-2737. (Pubitemid 44741577)
24. Chang JC, Naqvi T. Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer. Oncologist. 2003;8:375-380. (Pubitemid 36929722)
25. Chang JC. The understanding of thrombotic thrombocytopenic purpura: Dyadic, triadic, pentadic, and other manifestations. J Clin Apher. 2004;19:2-4. (Pubitemid 38509395)
26. Chatelet V, Fremeaux-Bacchi V, Lobbedez T, Ficheux M, Hurault de Ligny B. Safety and long-term efficacy of eculizumab in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome. Am J Transplant. 2009;9:2644-2645.
27. Chevalet P, Moreau A, Muller F, Berthelot JM, Hamidou M, Prost A. EExtensive bone marrow necrosis and thrombotic microangiopathic anemia revealing disseminated adenocarcinoma. Presse Med. 1998;27:1213-1215. (Pubitemid 28350932)
28. Cohan M, Pittman G, Hoffmann GC. Hemolytic anemia, tumor cell emboli, and intravascular coagulation. Arch Pathol. 1972;93: 305-307.
29. Collins PW, Jones L, Pocock C, Newland AC. Microangiopathic haemolysis associated with occult carcinoma. Clin Lab Haematol. 1991;13:245-249.
30. Coppo P, Schwarzinger M, Buffet M,Wynckel A, Clabault K, Presne C, Poullin P, Malot S, Vanhille P, Azoulay E, Galicier L, Lemiale V, Mira JP, Ridel C, Rondeau E, Pourrat J, Girault S, Bordessoule D, Saheb S, Ramakers M, Hamidou M, Vernant JP, Guidet B, Wolf M, Veyradier A; French Reference Center for Thrombotic Microangiopathies. Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience. PLoS One. 2010;5:e10208.
31. Crain SM, Choudhury AM. Thrombotic thrombocytopenic purpura in a splenectomized patient with Hodgkin's disease. Am J Med Sci. 1980;280:35-40. (Pubitemid 10002471)
32. Crespo-Valades E, Espinosa-Magro MP, Marco-Schulke C. EMetastatic gastric adenocarcinoma with microangiopathic hemolytic anemia. Rev Esp Enferm Dig. 2010;102:511-512.
33. Davis S, Rambotti P, Grignani F, Steinhouse K. Microangiopathic hemolytic anemia and pulmonary small-cell carcinoma. Ann Intern Med. 1985;103:638.
34. Deganello A, Franchi A, Sardi I, Pignataro L, Leemans CR, Gallo O. Genetic alterations between primary head and neck squamous cell carcinoma and recurrence after radiotherapy: recurrence, genetically related cancer, or second primary? Cancer. 2010;116:1291-1297.
35. Delsol G, Guiu-Godfrin B, Guiu M, Pris J, Corberand J, Fabre J. Leukoerythroblastosis and cancer frequency, prognosis, and physiopathologic significance. Cancer. 1979;44:1009-1013. (Pubitemid 10242235)
36. Dragon-Durey MA, Blanc C, Garnier A, Hofer J, Sethi SK, Zimmerhackl LB. Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimmune form of HUS. Semin Thromb Hemost. 2010;36:633-640.
37. Dumoulin-Lagrange M, Tulliez M, Diebold J, Samama M, Bousser J. EThrombotic thrombopenic purpura associated with Hodgkin's disease. Nouv Rev Fr Hematol. 1983;25:275-276.
38. Elliott MA, Letendre L, Gastineau DA,Winters JL, Pruthi RK, Heit JA. Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic consideration. Eur J Haematol. 2010;85:43-50.
39. Eugene M, Deray G, Cacoub P, Achour A, Baumelou A. Hemolytic uremic syndrome and prostatic adenocarcinoma. Clin Nephrol. 1987;27:46.
40. Ferretti G, Petti MC, Carlini P, Zeuli M, Picardi A, Meloni G, Bria E, Papaldo P, Fabi A, Cognetti F. Zoledronic acid-associated thrombotic thrombocytopenic purpura. Ann Oncol. 2004;15:1847-1848. (Pubitemid 40012252)
41. Fontana S, Gerritsen HE, Kremer Hovinga J, Furlan M, Lammle B. Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the vonWillebrand factor-cleaving protease. Br J Haematol. 2001;113:100-102. (Pubitemid 32423309)
42. Franchini M, Montagnana M, Targher G, Lippi G. Reduced von Willebrand factor-cleaving protease levels in secondary thrombotic microangiopathies and other diseases. Semin Thromb Hemost. 2007;33:787-797. (Pubitemid 351158447)
43. Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist. 2007;12:11-19. (Pubitemid 46143499)
44. Fujimura Y, Matsumoto M. Registry of 919 patients with thrombotic microangiopathies across Japan: database of Nara Medical University during 1998-2008. Intern Med. 2010;49:7-15.
45. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998;339:1578-1584. (Pubitemid 28536132)
46. Gami AS, Hayman SR, Grande JP, Garovic VD. Incidence and prognosis of acute heart failure in the thrombotic microangiopathies. Am J Med. 2005;118:544-547. (Pubitemid 40615479)
47. Geissler RG, Ganser A, Hubner K, Hor G, Hoelzer D. E47-year-old patient with pulmonary hypertension, anemia and thrombocytopenia. Internist (Berl). 1995;36:385-388.
48. Généreau T, De Cagny B, Branger B, Chérin P, Bentata M, Brivet F, Korach JM, Guillevin L. EMicroangiopathic hemolytic anemia associated with cancers. Symptomatic treatment by plasma exchange. Ann Med Interne (Paris). 1994;145:365-368.
49. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med. 2006;354:1927-1935. (Pubitemid 43872694)
50. George JN. How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood. 2010;116:4060-4069.
51. Gillett MJ, Arenson RV, Yew MK, Thompson IJ, Irish AB. Diagnostic challenges associated with a complex case of cystic phaeochromocytoma presenting with malignant hypertension, microangiopathic haemolysis and acute renal failure. Nephrol Dial Transplant. 2005;20:1014. (Pubitemid 40704050)
52. Girard P, Tardy B, Page Y, Mosnier JF, Tardy-Poncet B, Bertrand JC. EThrombotic thrombocytopenic purpura disclosing cancer: apropos of 2 cases. Presse Med. 1995;24:175-178.
53. Goldberg RJ, Nakagawa T, Johnson RJ, Thurman JM. The role of endothelial cell injury in thrombotic microangiopathy. Am J Kidney Dis. 2010;56:1168-1174.
54. González N, Ŕos E, Mart́n-Noya A, Rodŕguez JM. Thrombotic thrombocytopenic purpura and bone marrow necrosis as a complication of gastric neoplasm. Haematologica. 2002;87:ECR01.
55. Gordon LI, Kwaan HC. Thrombotic microangiopathy manifesting as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in the cancer patient. Semin Thromb Hemost. 1999;25:217-221. (Pubitemid 29227150)
56. Gusakova I, Mermershtain W, Cohen Y, Ariad S. Small bowel adenocarcinoma in Crohn disease patient complicated by microangiopathic hemolytic anemia. Am J Clin Oncol. 2003;26:483-485. (Pubitemid 37248266)
57. Hamilton CA, Kao JM, Coutre SE, Teng NN. Acute postoperative thrombotic thrombocytopenic purpura following hysterectomy and lymphadenectomy for endometrial cancer. Gynecol Oncol. 2007;106:423-426. (Pubitemid 47087934)
58. Hansen RM, Hanson GA. Gastric carcinoma in young people. A case report and review of the literature. Am J Gastroenterol. 1980;74:497-503. (Pubitemid 11146850)
59. Hauser I, Lechner K. Solid tumors and factor VIII antibodies. Thromb Haemost. 1999;82:1005-1007. (Pubitemid 29419708)
60. Himmelmann A, Schefer H. Microangiopathic haemolytic anaemia in a patient with metastatic breast cancer. Br J Haematol. 2009;146:231.
61. Hofmeister CC, Jin M, Cataland SR, Benson DM, Wu HM. TTP disease course is independent of myeloma treatment and response. Am J Hematol. 2010;85:304-306.
62. Honnorat J. Onconeural antibodies are essential to diagnose paraneoplastic neurological syndromes. Acta Neurol Scand Suppl. 2006;183:64-68.
63. Horne MK III, Cooper B. Microangiopathic hemolytic anemia with metastatic adenocarcinoma: response to chemotherapy. South Med J. 1982;75:503-504. (Pubitemid 12010421)
64. Hughes C, McEwan JR, Longair I, Hughes S, Cohen H, Machin S, Scully M. Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13. J Thromb Haemost. 2009;7:529-536.
65. Hussain S, Chui S. Gastric carcinoma presenting with extensive bone metastases and marrow infiltration causing extradural spinal haemorrhage. Br J Radiol. 2006;79:261-263.
66. Jilma-Stohlawetz P, Gorczyca ME, Jilma B, Siller-Matula J, Gilbert JC, Knöbl P. Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura. Thromb Haemost. 2011;105:545-552.
67. Kadikoylu G, Barutca S, Tataroglu C, Kafkas S, Erpek H, Meydan N, Yavasoglu I, Bolaman Z. Thrombotic thrombocytopenic purpura as the first manifestation of metastatic adenocarcinoma in a young woman. Transfus Apher Sci. 2010;42:39-42.
68. Kaidar-Person O, Nasrallah H, Haim N, Dann EJ, Bar-Sela G. Disseminated carcinoma diagnosed by bone marrow biopsy in patients with microangiopathic hemolytic anemia and thrombocytopenia: a report of two cases with gastric cancer and a review of the literature. J Gastrointest Cancer. 2010;42:123-126.
69. Kamesaki H, Matsui Y, Ohno Y, Amano H, Imanaka T, Takahashi Y, Kobashi Y, Kawakami K, Kita K. Angiotropic lymphoma with histologic features of neoplastic angioendotheliomatosis presenting with predominant respiratory and hematologic manifestations. Report of a case and review of the literature. Am J Clin Pathol. 1990; 94:768-772.
70. Kanesvaran R, Phipps C, Cheng CW, Chan MM, Khoo D, Tan MH. Management of thrombotic thrombocytopenic purpura in metastatic prostate cancer with only endocrine therapy. Ann Acad Med Singapore. 2010;39:580-582.
71. Kanou T, Nosou Y, Yoshinaka K, Yanagawa E, Niimoto M, Hattori T, Miura K, Kuramoto J. EMicroangiopathic hemolytic anemia associated with gastric cancer. Gan No Rinsho. 1986;32:1029-1034.
72. Kawahara M, Kanno M, Matsumoto M, Nakamura S, Fujimura Y, Ueno S. Diffuse neurodeficits in intravascular lymphomatosis with ADAMTS13 inhibitor. Neurology. 2004;63:1731-1733. (Pubitemid 39507604)
73. Köse O, Zimmerhackl LB, Jungraithmayr T, Mache C, Nürnberger J. New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab. Semin Thromb Hemost. 2010;36:669-672.
74. Kouides PA, Phatak PD, Cramer SF. Fatal thrombotic thrombocytopenic Purpura (TTP) presenting concurrently with metastatic multiple endocrine neoplasia (MEN) type I. Hematopathol Mol Hematol. 1996;10:161-170.
75. Kovacs K, Garvey MB. Thrombotic thrombocytopenic purpura associated with a prolactin-producing pituitary adenoma. Am J Hematol. 2003;74:55-59. (Pubitemid 37040195)
76. Krauth MT, Puthenparambil J, Lechner K. Paraneoplastic autoimmune thrombocytopenia in solid tumors. Crit Rev Oncol Hematol. 2012;81:75-81. Epub 2011 Apr 22.
77. Lakshminarayana G, Rajesh R, Seethalekshmy NV, Kurian G, Unni VN. Thrombotic microangiopathy with severe renal failure in adenocarcinoma. Indian J Nephrol. 2008;18:74-76.
78. Laso FJ, González-D́az M, Paz JI, De Castro S. Bone marrow necrosis associated with tumor emboli and disseminated intravascular coagulation. Arch Intern Med. 1983;143:2220.
79. Lee JL, Lee JH, Kim MK, Cho HS, Bae YK, Cho KH, Bae SH, Ryoo HM, Lee KH, Hyun MS. A case of bone marrow necrosis with thrombotic thrombocytopenic purpura as a manifestation of occult colon cancer. Jpn J Clin Oncol. 2004;34:476-480. (Pubitemid 43115295)
80. Levandovsky M, Harvey D, Lara P, Wun T. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients. J Hematol Oncol. 2008;1:23.
81. Liedtke C, Broglio K, Moulder S, Hsu L, Kau SW, Symmans WF, Albarracin C, Meric-Bernstam F, Woodward W, Theriault RL, Kiesel L, Hortobagyi GN, Pusztai L, Gonzalez-Angulo AM. Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer. Ann Oncol. 2009;20:1953-1958.
82. Lin YC, Chang HK, Sun CF, Shih LY. Microangiopathic hemolytic anemia as an initial presentation of metastatic cancer of unknown primary origin. South Med J. 1995;88:683-687.
83. Litt MR, Bell WR, Lepor HA. Disseminated intravascular coagulation in prostatic carcinoma reversed by ketoconazole. JAMA. 1987;258: 1361-1362. (Pubitemid 17132845)
84. Majhail NS, Hix JK, Almahameed A. Carcinoma of the colon in a patient presenting with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Mayo Clin Proc. 2002;77:873. (Pubitemid 34847727)
85. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood. 2001;98:2730-2735.
86. Mannucci PM, Karimi M, Mosalaei A, Canciani MT, Peyvandi F. Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 (von Willebrand factor cleaving protease). Haematologica. 2003;88:454-458. (Pubitemid 36547132)
87. Marcoullis G, Abebe L, Jain D, Talusan R, Bhagwati N, Wiernik PH. Microangiopathic hemolysis refractory to plasmapheresis responding to docetaxel and cisplatin: a case report. Med Oncol. 2002;19:189-192. (Pubitemid 35370338)
88. Mariette X, Oberlin F, Brigant S, Koeger AC, Camus JP. EMicroangiopathic hemolytic anemia in cancers. A case with remission after chemotherapy. Rev Med Interne. 1988;9:297-299.
89. Mauron H, Streuli R. EAnemia, subcutaneous bleeding and weight loss. Disseminated metastasizing, mucinous adenocarcinoma of the stomach. Praxis (Bern 1994). 2000;89:1568-1572.
90. McGregor AR, Moore ML, Bailey RR, Robson RA, Lynn KL. Disseminated prostatic carcinoma presenting with acute interstitial nephritis and microangiopathic haemolytic anaemia. Aust N Z J Med. 1990;20:170-172. (Pubitemid 20283026)
91. Microangiopathic anemia and disseminated intravascular coagulation in an elderly woman. Am J Med. 1983; 74: 1052Y 1060.
92. Mizuno I, Izeki O, Nakahara S, Kawamoto K, Onga T, Matsuoka H, Sugimoto T, Matsui T, Itoh H, Chihara K. EDisseminated carcinomatosis of the bone marrow occurring 11 years after subtotal gastrectomy for gastric cancer. Rinsho Ketsueki. 1998;39:670-675.
93. Moake J. Thrombotic microangiopathies: multimers, metalloprotease, and beyond. Clin Transl Sci. 2009;2:366-373.
94. Morishita T, Matsumoto M, Honoki K, Yoshida A, Takakura Y, Fujimura Y. Successful treatment of primitive neuroectodermal tumor-associated microangiopathy with multiple bone metastases. Jpn J Clin Oncol. 2007;37:66-69. (Pubitemid 47090726)
95. Moses J, Lichtman SM, Brody J, Wisch N, Moake J. Hairy cell leukemia in association with thrombotic thrombocytopenic purpura and factor VIII antibodies. Leuk Lymphoma. 1996;22:351-354. (Pubitemid 26318726)
96. Muller NJ, Pestalozzi BC. Hemolytic uremic syndrome in prostatic carcinoma. Oncology. 1998;55:174-176. (Pubitemid 28052263)
97. Mungall S, Mathieson P. Hemolytic uremic syndrome in metastatic adenocarcinoma of the prostate. Am J Kidney Dis. 2002;40:1334-1336. (Pubitemid 35403148)
98. Narita M, Nakao K, Ogino N, Emoto T, Nakahara M, Yumiba T, Tsujimoto M. A case of microangiopathic hemolytic anemia associated with breast cancer: improvement with chemoendocrine therapy. Breast Cancer. 1997;4:39-42.
99. Neidhardt B, Hartwich G, Preiss G, Schneider M. EMicroangiopathic hemolytic anemia in metastasizing appendiceal carcinoma. Med Welt. 1979;30:1822-1826. (Pubitemid 10216333)
100. Ng HJ, Crowther MA. Malignancy-associated venous thrombosis with concurrent warfarin-induced skin necrosis, venous limb gangrene and thrombotic microangiopathy. Thromb Haemost. 2006;95: 1038-1039. (Pubitemid 43933765)
101. Niscola P, Palmieri MB, Scaramucci L, Vischini G, Giovannini M, Ferrannini M, Palumbo R, Fratoni S. Fulminant thrombotic microangiopathy as a clinical presentation of an occult signet-ring cell carcinoma of the lung and misdiagnosed as idiopathic thrombotic thrombocytopenic purpura. Saudi Med J. 2010;31:581.
102. Nishimura M, Komori A, Matsushita M, Fukutani A, Fujiyama Y, Bamba T. Malignant gastrointestinal stromal tumor of the small intestine: rare complication of acute disseminated intravascular coagulation without hematogenous metastasis. Dig Dis Sci. 1998;43:2271-2277. (Pubitemid 28487258)
103. Noda N, Sano T, Shirao K, Ono H, Katai H, Sasako M, Maruyama K. A case of bone marrow recurrence from gastric carcinoma after a nine-year disease-free interval. Jpn J Clin Oncol. 1996;26: 472-475. (Pubitemid 126471809)
104. Nordstrom B, Strang P. Microangiopathic hemolytic anemias (MAHA) in cancer. A case report and review. Anticancer Res. 1993;13: 1845-1849. (Pubitemid 24008115)
105. Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361:1676-1687.
106. Oberic L, Buffet M, Schwarzinger M, Veyradier A, Clabault K, Malot S, Schleinitz N, Valla D, Galicier L, Bengrine-Lefevre L, Gorin NC, Coppo P; Reference Center for the Management of Thrombotic Microangiopathies. Cancer awareness in atypical thrombotic microangiopathies. Oncologist. 2009;14:769-779.
107. Oleksowicz L, Bhagwati N, DeLeon-Fernandez M. Deficient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies. Cancer Res. 1999;59:2244-2250. (Pubitemid 29217692)
108. Ortega Marcos O, Escuin F, Miguel JL, Gómez Fernández P, Pérez Fontán M, Selgas R, Sanchez Sicilia L. Hemolytic uremic syndrome in a patient with gastric adenocarcinoma: partial recovery of renal function after gastrectomy. Clin Nephrol. 1985;24:265-268. (Pubitemid 16229378)
109. Otrock ZK, Taher AT, Makarem JA, Kattar MM, Nsouli G, Shamseddine AI. Thrombotic thrombocytopenic purpura and bone marrow necrosis associated with disseminated gastric cancer. Dig Dis Sci. 2007;52:1589-1591. (Pubitemid 46776492)
110. Ozgüroglu M, Demirelli F, Mandel NM. Microangiopathic hemolytic anemia as an early predictor of recurrence in gastric cancer. Am J Clin Oncol. 1999;22:214. (Pubitemid 30263358)
111. Pasquini E, Gianni L, Aitini E, Nicolini M, Fattori PP, Cavazzini G, Desiderio F, Monti F, Forghieri ME, Ravaioli A. Acute disseminated intravascular coagulation syndrome in cancer patients. Oncology. 1995;52:505-508.
112. Patschan D,Witzke O, Dührsen U, Erbel R, Philipp T, Herget-Rosenthal S. Acute myocardial infarction in thrombotic microangiopathiesVclinical characteristics, risk factors and outcome. Nephrol Dial Transplant. 2006;21:1549-1554. (Pubitemid 44063126)
113. Paydas S, Ergin M, Baslamisli F, Yavuz S, Zorludemir S, Sahin B, Bolat FA. Bone marrow necrosis: clinicopathologic analysis of 20 cases and review of the literature. Am J Hematol. 2002;70:300-305. (Pubitemid 34810507)
114. Peyvandi F, Palla R, Lotta LA. Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura. Haematologica. 2010;95:1444-1447.
115. Pietra CD, Gudat F, Obrecht P, Hartmann D. EMicroangiopathic hemolytic anemia in malignant tumors. 2 cases. Schweiz Med Wochenschr. 1978;108:357-362.
116. Pinckard JK, Wick MR. Tumor-related thrombotic pulmonary microangiopathy: review of pathologic findings and pathophysiologic mechanisms. Ann Diagn Pathol. 2000;4:154-157. (Pubitemid 30480213)
117. Pirrotta MT, Bucalossi A, Forconi F, Bocchia M, Mazzotta S, Sammassimo S, Gozzetti A, Lauria F. Thrombotic thrombocytopenic purpura secondary to an occult adenocarcinoma. Oncologist. 2005;10:299-300. (Pubitemid 40559595)
118. Plaimauer B, Kremer Hovinga JA, Juno C, Wolfsegger MJ, Skalicky S, Schmidt M, Grillberger L, Hasslacher M, Knöbl P, Ehrlich H, Scheiflinger F. Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies. J Thromb Haemost. 2011;9:936-944.
119. Pogliani EM, Fowst C, Maffé P, Marozzi A, Stefani M, Polli E. CNS metastasis in ovarian cancer with microangiopathic hemolytic anemia associated with diffuse intravascular coagulation. Tumori. 1988;74:731-736. (Pubitemid 19068655)
120. Polukhin E, Balla A, Chary K, Mezhir J. Microangiopathic hemolytic anemia as the first manifestation of lung adenocarcinoma. South Med J. 2001;94:550-551. (Pubitemid 33643496)
121. Pusztai L, Viale G, Kelly CM, Hudis CA. Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis. Oncologist. 2010;15:1164-1168.
122. Puthenparambil J, Lechner K, Kornek G. Autoimmune hemolytic anemia as a paraneoplastic phenomenon in solid tumors: A critical analysis of 52 cases reported in the literature. Wien Klin Wochenschr. 2010;122:229-236.
123. Qu L, Kiss JE. Thrombotic microangiopathy in transplantation and malignancy. Semin Thromb Hemost. 2005; 31: 691Y 699. (Pubitemid 43063087)
124. Rauh MJ, Al Habeeb A, Chang H. Microangiopathic hemolytic anemia and leukoerythroblastic blood film heralding bone marrow metastatic gastroesophageal adenocarcinoma. Pathol Res Pract. 2011;207:121-123.
125. Robson MG, Abbs IC. Thrombotic thrombocytopenic purpura following hemicolectomy for colonic carcinoma. Nephrol Dial Transplant. 1997;12:198-199. (Pubitemid 27046229)
126. Rodenburg CJ, Nooy MA, Briët E. Microangiopathic haemolytic anaemia with advanced breast carcinoma: improvement with chemotherapy. Neth J Med. 1985;28:169-171. (Pubitemid 15112273)
127. Sakai C, Takagi T, Oguro M, Wakatsuki S, Kuwahara T. Malignant pheochromocytoma accompanied by microangiopathic hemolytic anemia: a case report. Jpn J Clin Oncol. 1994;24:171-174.
128. Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigounas G. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study. Thromb Haemost. 2001;86:828-833. (Pubitemid 32834193)
129. Salmeron M, Perrenoud JJ, Baumann RP. EDisseminated intravascular coagulation with microangiopathic hemolytic anemia and bone necrosis associated with a prostatic microcarcinoma. Schweiz Med Wochenschr. 1978;108:1549-1552. (Pubitemid 9017264)
130. Saltzman DJ, Chang JC, Jimenez JC, Carson JG, Abolhoda A, Newman RS, Milliken JC. Postoperative thrombotic thrombocytopenic purpura after open heart operations. Ann Thorac Surg. 2010;89:119-123.
131. Sato Y, Marutsuka K, Asada Y, Yamada M, Setoguchi T, Sumiyoshi A. Pulmonary tumor thrombotic microangiopathy. Pathol Int. 1995;45:436-440.
132. Schweizer H, Boehm J, Winterer JT, Wild D, Neumann HP, Wiech T, Stubanus M, Kuehn EW. Phaeochromocytoma and thrombotic microangiopathy: favourable outcome despite advanced renal failure. J Clin Pathol. 2010;63:754-756.
133. Sennesael JJ, Vanden Houte KM, Spapen HD, de Bruyne RM, Verbeelen DL. Recurrent hemolytic uremic syndrome and metastatic malignancy. Am J Nephrol. 1987;7:60-64. (Pubitemid 17037529)
134. Seo DW, Lee YS, Chae JG, Lee MG, Choe GY, Chi HS, Min YI. Hepatocellular carcinoma associated hemolytic uremic syndrome unrelated to chemotherapy. J Korean Med Sci. 1994;9:254-258.
135. Sevinc A, Kalender ME, Pehlivan Y, Sari I, Camci C. Thrombotic thrombocytopenic purpura and bone marrow necrosis as the initial presentation of lung cancer. Clin Appl Thromb Hemost. 2007;13:449-452. (Pubitemid 350114512)
136. Sill H, Höfler G, Kaufmann P, Horina J, Spuller E, Kleinert R, Beham-Schmid C. Angiotropic large cell lymphoma presenting as thrombotic microangiopathy (thrombotic thrombocytopenic purpura). Cancer. 1995;75:1167-1170.
137. Solenthaler M, Lámmle B. ESevere hemorrhage, lymphocytosis and leukoerythroblastic blood pictureVdisseminated intravascular coagulation in metastatic prostate carcinoma and chronic lymphatic leukemia. Ther Umsch. 1999;56:533-536.
138. Spero JA, Lewis JH, Hasiba U. Disseminated intravascular coagulation. Findings in 346 patients. Thromb Haemost. 1980;43:28-33. (Pubitemid 10150450)
139. Spoormans I, Altintas S, Van den Brande J, Luijks A, Vermorken JB. Purpura in a patient with disseminated breast cancer: a rapidly progressive cancer-related thrombotic thrombocytopenic purpura. Ann Oncol. 2008;19:1204-1207. (Pubitemid 351796350)
140. Stopeck AT, Lipton A, Body JJ, Steger GG, Tonkin K, de Boer RH, Lichinitser M, Fujiwara Y, Yardley DA, Viniegra M, Fan M, Jiang Q, Dansey R, Jun S, Braun A. Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study. J Clin Oncol. 2010;28:5132-5139.
141. Susano R, Caminal L, Ferro J, Rubiales A, de Lera J, de Quirós JF. EMicroangiopathic hemolytic anemia associated with neoplasms: an analysis of 5 cases and a review of the literature. Rev Clin Esp. 1994;194:603-606.
142. Takeuchi R, Kuto M, Katayama N, Kamio N, Tsuda M, Nagano T, Tomeoku M,Wada H, Murashima S, Deguchi K, et al. ECarcinomatosis associated with microangiopathic hemolytic anemia and disseminated intravascular coagulation: 12 years after gastrectomy for gastric adenocarcinoma. Rinsho Ketsueki. 1983;24: 1423-1429.
143. Tauzin-Fin P, Sesay M, Ryman A, Ballanger P, Combe C. Postoperative thrombotic microangiopathy following radical cystectomy for bladder cancer. Anaesth Intensive Care. 2006;34:672-675. (Pubitemid 44687841)
144. Taylor FBJr, Toh CH, Hoots WK, Wada H, Levi M; Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327-1330.
145. Terrell DR, Vesely SK, Hovinga JA, Lämmle B, George JN. Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol. 2010;85:844-847.
146. Thompson AM, Jordan LB, Quinlan P, Anderson E, Skene A, Dewar JA, Purdie CA; the Breast Recurrence in Tissues Study Group. Prospective comparison of switches in biomarker status between primary and recurrent breast cancer: the Breast Recurrence In Tissues Study (BRITS). Breast Cancer Res. 2010;12:R92.
147. Trpin L, Molinari E, Ascari E. EMicroangiopathic haemolytic anaemia in prostatic cancer. Haematologica. 1977;62:185-192.
148. Turitto G, Annunziata M, Barletta E, Lombardi R, Tinessa V, Daniele B. Thrombotic thrombocytopenic purpura in patient with metastatic occult adenocarcinoma. A case report. Recenti Prog Med. 2006;97:197-199.
149. van den Born BJ, van der Hoeven NV, Groot E, Lenting PJ, Meijers JC, Levi M, van Montfrans GA. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension. 2008;51:862-866. (Pubitemid 351654696)
150. Van der Merwe WM, Collins JF. The haemolytic uraemic syndrome and prostatic carcinoma. N Z Med J. 1987;100:483-485. (Pubitemid 18083874)
151. Vasko R, Koziolek M, Fuzesi L, König F, Strutz F, Müller GA. Fulminant plasmapheresis-refractory thrombotic microangiopathy associated with advanced gastric cancer. Ther Apher Dial. 2010;14:222-225.
152. Vesely SK, George JN, Lammle B, Studt JD, Alberio L, El-Harake MA, Raskob GE. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood. 2003;102:60-68. (Pubitemid 36759636)
153. von Bubnoff N, Sandherr M, Schneller F, Peschel C. Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast. Am J Clin Oncol. 2000;23:74-77. (Pubitemid 30407366)
154. Watzka SB, Rauscher-Pötsch I, Nierlich P, Setinek U, Kostler WJ, Potschger U, Muller MR, Attems J. Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases: a post-mortem study. Eur J Cardiothorac Surg. 2010;38:34-37.
155. Werner TL, Agarwal N, Carney HM, Rodgers GM. Management of cancer-associated thrombotic microangiopathy: what is the right approach? Am J Hematol. 2007;82:295-298. (Pubitemid 46566332)
156. Wolff D, Brinkmann B, Emmrich J, Steiner M. Metastatic pancreatic carcinoma presenting as thrombotic thrombocytopenic purpura. Pancreas. 2003;26:314. (Pubitemid 36384170)
157. Wong KF, Chan JK, Ma SK. Solid tumour with initial presentation in the bone marrowVa clinicopathologic study of 25 adult cases. Hematol Oncol. 1993;11:35-42. (Pubitemid 23192251)
158. Yokomine T, Hirakawa H, Ozawa E, Shibata K, Nakayama T. Pulmonary thrombotic microangiopathy caused by gastric carcinoma. J Clin Pathol. 2010;63:367-369.
159. Zimmerhackl LB, Hofer J, Cortina G, Mark W, Würzner R, Jungraithmayr TC, Khursigara G, Kliche KO, RadauerW. Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome. N Engl J Med. 2010;362:1746-1748.
160. Zupancic M, Shah PC, Shah-Khan F. Successful splenectomy in cancer-associated TTP. Am J Hematol. 2007;82:250-251.